ARLEVERT

This brand name is authorized in Austria, Estonia, Finland, Ireland, Lithuania, Mexico, Poland, Romania, UK.

Active ingredients

The drug ARLEVERT contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 3DI2E1X18L - CINNARIZINE
 

Cinnarizine has been shown to be a non-competitive antagonist of the smooth muscle contractions caused by various vasoactive agents including histamine. Cinnarizine also acts on vascular smooth muscle by selectively inhibiting the calcium influx into depolarised cells, thereby reducing the availability of free Ca2+ ions for the induction and maintenance of contraction.

 
Read more about Cinnarizine
2
UNII JB937PER5C - DIMENHYDRINATE
 

Dimenhydrinate is a theoclate salt of the ethanolamine derivative diphenhydramine. It exhibits reversible competitive antagonism with histamine for the capture of H1 receptors. It has anticholinergic (antimuscarinic) properties that explain the anti-emetic action of the drug in cases of labyrinthial irritation (nausea, vertigo), and the central suppression it causes.

 
Read more about Dimenhydrinate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N07CA52 Cinnarizine, combinations N Nervous system → N07 Other nervous system drugs → N07C Antivertigo preparations → N07CA Antivertigo preparations
Discover more medicines within N07CA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1546781, 1546792, 1546804, 1864874, 1864885, 1864896, 1864908, 1864919, 1864920
FI Lääkealan turvallisuus- ja kehittämiskeskus 098005, 098023
GB Medicines & Healthcare Products Regulatory Agency 110655
LT Valstybinė vaistų kontrolės tarnyba 1063159, 1070411, 1070412
MX Comisión Federal para la Protección contra Riesgos Sanitarios 283M2015
PL Rejestru Produktów Leczniczych 100195727
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W02144001, W02144003, W02144004, W02144005, W02144006, W02144007

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.